E Lamperti
Overview
Explore the profile of E Lamperti including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
57
Citations
263
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Scaratti C, Leonardi M, Saladino A, Anghileri E, Broggi M, Lamperti E, et al.
Support Care Cancer
. 2017 Feb;
25(7):2137-2145.
PMID: 28204993
Purpose: The aims of this study are to identify neuro-oncological patients' and their caregivers' needs during hospitalization (T0) and at 4 months after discharge (T1); to analyze the longitudinal changes...
2.
Simonetti G, Gaviani P, Lamperti E, Innocenti A, Botturi A, Saini M, et al.
Neurol Sci
. 2016 Jun;
37(10):1727-30.
PMID: 27329275
Medulloblastomas and high-grade gliomas (HGG) are two distinct brain tumor, with different peculiarities in terms of age of onset, localizations and prognosis. The coexistence of the two neoplasms in the...
3.
Gaviani P, Simonetti G, Innocenti A, Lamperti E, Botturi A, Silvani A
Neurol Sci
. 2015 Aug;
37(1):131-133.
PMID: 26292791
Elderly patients represent an important subgroup in primary central nervous system lymphoma (PCNSL) that accounts for approximately half the cases. Furthermore age represents one of the heaviest prognostic factors and...
4.
Simonetti G, Gaviani P, Botturi A, Innocenti A, Lamperti E, Silvani A
Cancer Manag Res
. 2015 Aug;
7:213-23.
PMID: 26251628
Oligodendrogliomas represent the third most common type of glioma, comprising 4%-15% of all gliomas and can be classified by degree of malignancy into grade II and grade III, according to...
5.
Lucchiari C, Botturi A, Silvani A, Lamperti E, Gaviani P, Innocenti A, et al.
Support Care Cancer
. 2015 Mar;
23(12):3427-35.
PMID: 25761757
The purpose of this study was to analyze the psychological well-being, quality of life, and cognitive strategies activated by patients with high-grade glioma. We hypothesized that the self-perceived quality of...
6.
Simonetti G, Gaviani P, Innocenti A, Botturi A, Lamperti E, Silvani A
Neurol Sci
. 2014 May;
35(7):977-81.
PMID: 24859855
Anaplastic gliomas (AG) include 6-10% of all newly diagnoses of primary brain tumors. They have an unfavourable prognosis and, to date, there is not an established treatment universally recognized. Four...
7.
Simonetti G, Trevisan E, Silvani A, Gaviani P, Botturi A, Lamperti E, et al.
Neurol Sci
. 2013 Nov;
35(1):83-9.
PMID: 24281944
Angiogenesis has recently become a major target for the development of new antineoplastic drugs. The most serious adverse events linked to angiogenesis inhibitors are venous or arterial thromboembolism and haemorrhage....
8.
Gaviani P, Simonetti G, Salmaggi A, Lamperti E, Silvani A
J Neurooncol
. 2013 May;
113(3):527-9.
PMID: 23703296
No abstract available.
9.
Gaviani P, Corsini E, Salmaggi A, Lamperti E, Botturi A, Erbetta A, et al.
Neurol Sci
. 2013 Mar;
34(12):2151-7.
PMID: 23525755
Neoplastic meningitis (NM) is diagnosed in 1-2 % of patients with primary brain tumors. Standard treatment of NM includes single-agent or combination chemotherapy, with compounds such as methotrexate, thiotepa, and...
10.
Botturi A, Lamperti E, Finocchiaro C, Berrini F, Ferrari D, Fariselli L, et al.
Neurol Sci
. 2011 Oct;
32 Suppl 2:S221-4.
PMID: 22012628
Informed consent is often talked about in an abstract manner, as if consent and information necessarily have to go together, and almost as if consent is "naturally" the quintessence of...